Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Among urothelial cancer patients treated with atezolizumab, those who used PPIs had a 68 percent greater risk of death.
The oral targeted therapy lowered the risk of relapse in a late-stage study.
Black patients should also benefit from recently approved PARP Inhibitor therapies “if applied equitably,” study finds
The treatment method was found to be safe and effective in comparison with surgery or radiation.
Adding the targeted drug to chemo and radiation treatment is safe and increases the chance that most of the tumor will die before surgery.
Keytruda plus chemotherapy reduced the risk of disease progression or death by 35% compared with chemotherapy alone in certain people.
The most aggressive type of skin cancer may respond to immunotherapy.
The pandemic raises new concerns, but it may also lead to long-lasting improvements.
A Phase 1 study on customized immunotherapy shows promise for people with lung cancer.
Women who took this drug in addition to standard chemotherapy lived longer than those who just received standard chemo.
More diversity would help doctors determine whether coronavirus treatments and vaccines will work for all population groups.
In recent years, deaths from non-small cell lung cancer (NSCLC) have decreased even faster than the decrease in NSCLC incidence.
These survivors are more likely to develop high cholesterol, high blood pressure, diabetes, thyroid disorder and other chronic conditions.
The cells reprogram themselves to absorb iron as a way to thrive and grow while other cells are left short.
Margaret has never stopped living and enjoying her life despite her disease and the side effects of her medication.
Instead of researching new treatment targets or experimental combination therapies, she focuses on patient experience and quality of life.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.